Please Note: MBL International will be shutting down its operations effective December 31, 2024. Distribution of MBL products in the United States will be transferred to Cosmo Bio US on January 1st while European Distributors will remain unchanged. For any US inquiries regarding orders or support during this transition, reach out to Cosmo Bio: https://www.cosmobiousa.com/. For Non-US inquiries reach out to MBL in Japan: https://www.mblbio.com/.

Skip to the main content.
Advanced MHC Tetramers Search

HLA-E & Qa-1b Non-Classical MHCs

HLA-E

HLA-E is a non-classical MHC Class 1b molecule expressed ubiquitously in humans. These molecules are key players in the innate and acquired immune response.

  • HLA-E is recognized by the CD92/NKG2 receptor on NK cells and the T-cell receptor (TCR) on NKT cells. CD92/NKG2 receptor recognition allows for modulation of cytotoxicity and cytokine release by NK cells1
  • HLA-E molecules are involved in presentation of antigenic peptides to CD8+ T-cells through the αβ TCRs1
  • HLA-E molecules present microbial-derived peptides from human viruses or bacteria1
  • HLA-E molecules function as restriction elements for specific T-cell mediated responses against pathogens such as mycobacteria, the Cytomegalovirus (CMV), and the Epstein-Barr virus (EBV)1

HLA-E is recognized by the CD92/NKG2 receptor on NK cells and the T-cell receptor (TCR) on NKT cells.

HLA-E is a key research target in combating disease conditions:

  • HLA-E could potentially interact with HIV-1 gag/Capsid protein p24-derived peptide allowing HIV-1 to evade immune surveillance2
  • HLA-E interacts with SARS-CoV-2 S/Spike protein S1 derived peptide on the lung epithelial cell surface leading to exhaustion of NK cells and dampening of anti-viral immune surveillance3

Two functional HLA-E alleles have been observed- HLA-E*01:01 and HLA-E*01:03.

MBL International offers HLA-E tetramers comprised of human class I HLA-E*01:03 and epitope peptide derived from the HLA-A leader. The tetramer allows for detection of HLA-E*01:03-restricted HLA-A leader3-11-specific NK cells and CD8+ T cells by flow cytometry.

Nonclassical_Picture_2-1024x618-2

SEE PRODUCTS

Qa-1b

The Qa-1b molecule is the murine non-classical MHC class 1 homolog of HLA-E. It is characterized by limited polymorphism and is similar in function to the HLA-E molecule.5

MBL International offers biotinylated Qa-1b custom monomers and tetramers available tagged with PE, APC or BV421.

SEE PRODUCTS

Research Highlights

HLA-E and Qa-1b have been researched extensively so far in 2021.

  • H Yang et al. demonstrated that invitro generation HIV-1 Gag-specific, HLA-E restricted CD8+ T cell clones was possible from naïve T-cells derived from HIV-1 negative individuals. The generated clones suppressed HIV-1 infected CD4+ target cells. This study suggests the design of a human CMV vector-based vaccine against HIV.4
  • H. Vietzen et al. demonstrated that an increased frequency of the heterozygous HLA-E*0101/0103 variant was seen in patients who displayed severe COVID-19 progression as compared to the homozygous HLA-E*0101 allele. It was also shown that NKG2C-drived NK cell responses may play a key role in virus infection and COVID-19 severity.5
  • X Zhang et al, have demonstrated functional cross talk between Qa-1b/HLA-E and classical TAP-dependent MHC complexes, especially in tumors that show impairment in the antigen processing machinery.6

References:

  1. Socié G, et al. Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation: 19-38 (2013)
  2. Natterman J, et al. Antiviral Therapy 10(1): 95-107 (2005)
  3. Bortolotti D, et al. Cells 9(9): 1975 (2020)
  4. Yang H, et al. Science Immunology 6(57) (2021)
  5. Vietzen H, et al. Genetics in Medicine 23: 963-967 (2021)
  6. Zhang X, et al. Tumor Microenvironment and Immunobiology 19(6): 1076-1084 (2021)